Novel PAT system could enable adaptive process control2 June 2023 | By Catherine Eckford (European Pharmaceutical Review)A paper has demonstrated a novel refractometry-based process analytical technology (PAT) system has potential for enabling adaptive process control in CGT manufacturing.
Sandoz to move headquarters to Basel, Switzerland2 June 2023 | By Catherine Eckford (European Pharmaceutical Review)As Sandoz prepares to become standalone company, the generic and biosimilar firm has declared it will base itself in Basel, facilitating closer collaboration.
New UK drug delivery centre to support RNA therapeutic development2 June 2023 | By Catherine Eckford (European Pharmaceutical Review)To develop new lipid nanoparticle formulations for RNA therapeutic delivery technologies, CPI and partners are working to establish a new UK Intracellular Drug Delivery Centre.
NICE recommends oral migraine treatment for first time1 June 2023 | By Catherine Eckford (European Pharmaceutical Review)An oral small molecule CGRP antagonist has been recommended for episodic migraines in National Institute for Health and Care Excellence (NICE) final draft guidance.
Microfluidic device detects bacteria concentration from small sample volumes1 June 2023 | By Catherine Eckford (European Pharmaceutical Review)A novel ultrasonic nanosieve enabled concentration of bacteria into a 1µL highly concentrated solution suitable for plate counting and PCR, according to research.
CRISPR-based microbial gene therapy delivers promise31 May 2023 | By Catherine Eckford (European Pharmaceutical Review)A microbial gene therapy can “eliminate antibiotic-resistant E. coli strains in the gut”, according to first-in-human study interim results.
Big Pharma inventory management trends revealed31 May 2023 | By Catherine Eckford (European Pharmaceutical Review)Rapid growth of Big Pharma manufacturer inventories fail to prevent medicine shortages, a 2022 report has highlighted.
European Commission approves haematology biosimilar30 May 2023 | By Catherine Eckford (European Pharmaceutical Review)A marketing authorisation for a biosimilar to eculizumab has been granted by the European Commission for paroxysmal nocturnal haemoglobinuria.
Automation to guide technology shift in aseptic environments29 May 2023 | By Catherine Eckford (European Pharmaceutical Review)Referencing Annex 1–2022, a paper has described how automation will be implemented in aseptic environments in view of regulatory requirements.
CHMP meeting highlights – May 202329 May 2023 | By Catherine Eckford (European Pharmaceutical Review)The Committee for Medicinal Products for Human Use (CHMP) recommended two new medicines for approval in its May meeting, including a neurosteroid for epileptic seizures.
New recognition routes to fast-track UK medicine access26 May 2023 | By Catherine Eckford (European Pharmaceutical Review)New recognition routes will facilitate faster and safer access to innovative medicines through seven international partners, according to the UK’s MHRA.
Life sciences sector to receive £650 million funding26 May 2023 | By Catherine Eckford (European Pharmaceutical Review)Funding to support the UK's life sciences manufacturing, skills and infrastructure has been announced as part of a £650m growth package.
Nanoparticle HIV vaccine shows potential in trial25 May 2023 | By Catherine Eckford (European Pharmaceutical Review)Positive first-in-human trial results have highlighted potential of a nanoparticle vaccine towards broadly neutralising against HIV.
Pharmapack Awards 2024 entries open25 May 2023 | By CPhIEntries are open for the Pharmapack Awards 2024, which aims to showcase innovations in global drug delivery and packaging.
Research outlines framework for robotic laboratory automation24 May 2023 | By Catherine Eckford (European Pharmaceutical Review)A paper has discussed a laboratory automation plug & play (LAPP) framework, of which a digital twin layer plays an important part.
